Brainstorm Cell Therapeutics Inc. (BCLI)

BCLI Statistics

Total Valuation

BCLI has a market cap or net worth of $7.89 million. The enterprise value is $8.53 million.

Market Cap	7.89M
Enterprise Value	8.53M

Important Dates

The next confirmed earnings date is Thursday, May 15, 2025, before market open.

Earnings Date	May 15, 2025
Ex-Dividend Date	n/a

Share Statistics

BCLI has 6.52 million shares outstanding. The number of shares has increased by 74.87% in one year.

Current Share Class	6.52M
Shares Outstanding	6.52M
Shares Change (YoY)	+74.87%
Shares Change (QoQ)	+7.50%
Owned by Insiders (%)	12.84%
Owned by Institutions (%)	10.13%
Float	5.55M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	-0.99
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.04

Current Ratio	0.04
Quick Ratio	0.03
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-151.86

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-241.99%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	163.63%
Revenue Per Employee	n/a
Profits Per Employee	-$430,481
Employee Count	27
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -82.16% in the last 52 weeks. The beta is 0.34, so BCLI's price volatility has been lower than the market average.

Beta (5Y)	0.34
52-Week Price Change	-82.16%
50-Day Moving Average	1.24
200-Day Moving Average	2.32
Relative Strength Index (RSI)	54.41
Average Volume (20 Days)	138,630

Short Selling Information

The latest short interest is 291,418, so 4.47% of the outstanding shares have been sold short.

Short Interest	291,418
Short Previous Month	346,646
Short % of Shares Out	4.47%
Short % of Float	5.25%
Short Ratio (days to cover)	1.05

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-11.69M
Pretax Income	-15.53M
Net Income	-11.62M
EBITDA	-11.45M
EBIT	-11.69M
Earnings Per Share (EPS)	-$2.31

Balance Sheet

The company has $187,000 in cash and $1.02 million in debt, giving a net cash position of -$833,000 or -$0.13 per share.

Cash & Cash Equivalents	187,000
Total Debt	1.02M
Net Cash	-833,000
Net Cash Per Share	-$0.13
Equity (Book Value)	-7.76M
Book Value Per Share	-1.26
Working Capital	-8.59M

Cash Flow

Operating Cash Flow	-9.09M
Capital Expenditures	n/a
Free Cash Flow	-9.09M
FCF Per Share	-$1.39

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BCLI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-74.87%
Shareholder Yield	-74.87%
Earnings Yield	-151.02%
FCF Yield	-118.15%

Analyst Forecast

The average price target for BCLI is $30.00, which is 2,379.34% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$30.00
Price Target Difference	2,379.34%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on October 1, 2024. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date	Oct 1, 2024
Split Type	Reverse
Split Ratio	0.0666667:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1